The U-M COVID-19 Preparedness and Response Plan applies in its entirety to research. As public health conditions change, researchers should refer to the U-M COVID-19 Preparedness and Response plan to guide when changes to their current mitigation strategies are allowable. The policies apply to research in all settings, both on and off campus.
Questions? Contact firstname.lastname@example.org.
CLINICAL TRIALS SUPPORT OFFICE
The Clinical Trials Support Office (CTSO) is the central hub for the seven trans-departmental Clinical Trials Support Units (CTSUs), providing enterprise-wide leadership, standards, policies, and a common infrastructure. All clinical research at Michigan Medicine that has a billing calendar is required to be supported by a CTSU, but some exceptions may apply.
In our role as concierge for clinical research, we act as a liaison between Principal Investigators and study teams to other partners across the U-M involved in clinical research. CTSO team members, also support OnCore, our integrated and comprehensive clinical trials management system.
Easier and more timely navigation through the administrative processes of clinical research at Michigan Medicine is our goal. If you are a faculty or study team member, CLICK HERE to start the clinical research process, or connect with us at CTSOgroup@umich.edu.
>>Not sure if your study is a Clinical Trial? Click here to view the NIH definition of a Clinical Trial.
CTSO METRICS: FY2021
During Fiscal Year 2021, over 66,511 patients participated in active clinical research studies at the CTSO. Of those studies that were open to enrollment, 41% were funded by industry, 15% funded nationally, 14% funded externally/peer-reviewed, and 17% were funded institutionally.